Edesa Biotech (EDSA) Short Interest Ratio & Short Volume $2.34 +0.01 (+0.43%) Closing price 05/1/2025 03:32 PM EasternExtended Trading$2.38 +0.04 (+1.67%) As of 05/1/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edesa Biotech Short Interest DataEdesa Biotech (EDSA) has a short interest of 54,500 shares, representing 0.90% of the float (the number of shares available for trading by the public). This marks a -25.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 489,777 shares to cover all short positions.Current Short Interest54,500 sharesPrevious Short Interest73,100 sharesChange Vs. Previous Month-25.44%Dollar Volume Sold Short$126,712.50Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares7,023,000 sharesFloat Size6,070,000 sharesShort Percent of Float0.90%Today's Trading Volume2,309 sharesAverage Trading Volume489,777 sharesToday's Volume Vs. Average0% Short Selling Edesa Biotech? Sign up to receive the latest short interest report for Edesa Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEDSA Short Interest Over TimeEDSA Days to Cover Over TimeEDSA Percentage of Float Shorted Over Time Edesa Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202554,500 shares $126,712.50 -25.4%0.9%0 $2.33 3/31/202573,100 shares $178,364.00 -25.0%1.2%0 $2.44 3/15/202597,400 shares $232,786.00 -9.2%1.6%0.1 $2.39 2/28/2025107,300 shares $234,987.00 -87.4%1.8%0.1 $2.19 2/15/2025852,100 shares $2.29 million +4,942.0%15.5%0.5 $2.69 1/31/202516,900 shares $32,194.50 +259.6%0.7%0.6 $1.91 1/15/20254,700 shares $8,225.00 -14.6%0.2%0.1 $1.75 12/31/20245,500 shares $9,240.00 -74.4%0.2%0.2 $1.68 12/15/202421,500 shares $41,626.15 -39.4%0.9%0.7 $1.94 11/30/202435,500 shares $86,620.00 -26.8%1.6%1.2 $2.44 Get the Latest News and Ratings for EDSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. 11/15/202448,500 shares $101,850.00 +192.2%2.2%2.1 $2.10 10/31/202416,600 shares $54,780.00 -16.2%0.8%0.8 $3.30 10/15/202419,800 shares $82,364.04 +58.4%0.9%1.9 $4.16 9/30/202412,500 shares $55,625.00 -25.6%0.6%1.3 $4.45 9/15/202416,800 shares $73,399.20 +14.3%0.8%2.1 $4.37 8/31/202414,700 shares $66,150.00 -8.7%0.7%1.8 $4.50 8/15/202416,100 shares $69,552.00 -12.5%0.7%1.5 $4.32 7/31/202418,400 shares $97,520.00 +2.8%0.8%1.7 $5.30 7/15/202417,900 shares $75,717.00 -0.6%0.8%2 $4.23 6/30/202418,000 shares $77,040.00 +13.9%0.8%2.2 $4.28 6/15/202415,800 shares $70,298.94 +6.8%0.7%1.7 $4.45 5/31/202414,800 shares $64,084.00 +32.1%0.7%1.7 $4.33 5/15/202411,200 shares $50,512.00 -30.4%0.5%1.3 $4.51 4/30/202416,100 shares $71,532.30 +5.9%0.7%1.5 $4.44 4/15/202415,200 shares $62,624.00 -22.1%0.7%1.2 $4.12 3/31/202419,500 shares $81,738.15 +10.2%0.8%1.4 $4.19 3/15/202417,700 shares $77,703.00 +4.1%0.8%1.2 $4.39 2/29/202417,000 shares $77,860.00 +11.8%0.7%0.6 $4.58 2/15/202415,200 shares $85,880.00 -27.6%0.7%0.5 $5.65 1/31/202421,000 shares $93,450.00 +2,525.0%0.9%0.7 $4.45 1/15/2024800 shares $3,728.00 -93.4%0.0%0 $4.66 12/31/202312,100 shares $55,297.00 -61.7%0.5%0.1 $4.57 12/15/202331,600 shares $164,004.00 +1,404.8%1.4%0.3 $5.19 11/30/20232,100 shares $6,930.00 -91.0%0.1%0 $3.30 11/15/202323,200 shares $67,280.00 -21.6%1.1%0.3 $2.90 10/31/202329,600 shares $95,312.00 -50.3%1.4%0.4 $3.22 10/15/202359,500 shares $235,322.50 -80.2%2.8%0.8 $3.96 9/30/2023300,200 shares $1.33 million -4.9%N/A3.5 $4.42 9/15/2023315,500 shares $283,950.00 -0.9%N/A6.5 $0.90 8/31/2023318,200 shares $269,515.40 -49.7%N/A5.8 $0.85Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 8/15/2023632,100 shares $537,285.00 -1.4%N/A11.5 $0.85 7/31/2023641,300 shares $525,866.00 -0.1%N/A10.8 $0.82 7/15/2023641,700 shares $534,471.93 -3.2%N/A8.9 $0.83 6/30/2023662,800 shares $530,240.00 +5.0%N/A9.6 $0.80 6/15/2023631,000 shares $542,218.30 -0.1%N/A8.7 $0.86 5/31/2023631,800 shares $574,938.00 -1.2%N/A7.9 $0.91 5/15/2023639,600 shares $562,911.96 -12.4%N/A8 $0.88 4/30/2023730,500 shares $818,160.00 -20.0%N/A8.6 $1.12 4/15/2023913,300 shares $958,965.00 +0.8%N/A9.5 $1.05 3/31/2023906,500 shares $826,818.65 +10.9%N/A4.9 $0.91 3/15/2023817,300 shares $980,760.00 +19.3%N/A1.7 $1.20 2/28/2023685,300 shares $979,979.00 +6.3%N/A1.4 $1.43 2/15/2023644,500 shares $928,080.00 -17.6%N/A1.3 $1.44 1/31/2023781,700 shares $1.17 million +16.7%N/A1.6 $1.50 1/15/2023669,600 shares $1.69 million -17.8%N/A1.4 $2.52 12/30/2022815,000 shares $1.76 million +111.0%N/A2.1 $2.16 12/15/2022386,300 shares $370,732.11 +4.4%3.2%0.9 $0.96 11/30/2022369,900 shares $341,121.78 +4.3%3.9%1.9 $0.92 11/15/2022354,800 shares $325,316.12 +6.2%3.7%1.8 $0.92 10/31/2022334,000 shares $344,020.00 +10.5%3.5%1.7 $1.03 10/15/2022302,300 shares $292,535.71 +484.7%3.0%1.5 $0.97 9/30/202251,700 shares $47,631.21 -38.7%0.5%0.3 $0.92 9/15/202284,300 shares $148,368.00 -11.9%0.8%1.2 $1.76 8/31/202295,700 shares $179,916.00 +476.5%1.0%1.3 $1.88 8/15/202216,600 shares $32,536.00 -73.7%0.2%0.2 $1.96 7/31/202263,000 shares $113,400.00 -5.8%0.6%0.9 $1.80 7/15/202266,900 shares $109,716.00 -22.9%0.7%1.2 $1.64 6/30/202286,800 shares $139,748.00 -26.4%0.9%1.4 $1.61 6/15/2022117,900 shares $200,430.00 +12.7%1.2%2 $1.70 5/31/2022104,600 shares $215,476.00 -18.9%1.0%1.5 $2.06 5/15/2022129,000 shares $241,230.00 -13.4%1.3%1.8 $1.87 4/30/2022149,000 shares $330,780.00 -1.9%1.6%2.1 $2.22 4/15/2022151,900 shares $429,877.00 +13.7%1.6%2 $2.83 3/31/2022133,600 shares $396,792.00 -42.7%1.5%1.5 $2.97 3/15/2022233,000 shares $719,970.00 -14.1%2.7%2.3 $3.09 2/28/2022271,300 shares $1.01 million -8.3%3.1%2.7 $3.71 2/15/2022295,900 shares $1.19 million -8.5%3.3%2.6 $4.02 1/31/2022323,300 shares $1.34 million +8.8%4.3%2.6 $4.14 1/15/2022297,300 shares $1.56 million +14.2%4.0%2 $5.26 12/31/2021260,300 shares $1.47 million -3.6%3.5%1 $5.63 12/15/2021270,100 shares $1.44 million -21.3%3.6%0.8 $5.34 11/30/2021343,100 shares $2.17 million -5.0%4.6%0.1 $6.32 11/15/2021361,100 shares $2.48 million -27.5%4.9%0.1 $6.86 10/29/2021498,100 shares $4.09 million -16.0%6.7%0.2 $8.22 10/15/2021593,200 shares $4.63 million -6.9%8.0%0.2 $7.81 9/30/2021637,000 shares $4.70 million +333.0%8.6%0.2 $7.38 9/15/2021147,100 shares $801,695.00 +87.2%2.0%0 $5.45 8/31/202178,600 shares $461,382.00 +216.9%1.1%0.8 $5.87 8/13/202124,800 shares $113,832.00 +19.2%0.3%0.2 $4.59 7/30/202120,800 shares $103,792.00 +17.5%0.3%0.2 $4.99Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 7/15/202117,700 shares $86,730.00 -35.6%0.2%0.1 $4.90 6/30/202127,500 shares $145,200.00 -19.4%0.4%0.2 $5.28 6/15/202134,100 shares $188,232.00 -35.2%0.5%0.2 $5.52 5/28/202152,600 shares $329,802.00 -60.1%0.7%0.3 $6.27 5/14/2021131,900 shares $774,253.00 +143.8%N/A0.5 $5.87 4/30/202154,100 shares $300,255.00 -30.7%N/A0.2 $5.55 4/15/202178,100 shares $426,426.00 -11.9%N/A0.1 $5.46 3/31/202188,600 shares $465,150.00 +180.4%N/A0.1 $5.25 3/15/202131,600 shares $176,960.00 -88.2%0.5%0.1 $5.60 2/26/2021268,800 shares $1.78 million +202.0%4.7%0.5 $6.61 2/12/202189,000 shares $623,890.00 -49.7%2.2%0.2 $7.01 1/29/2021176,900 shares $999,485.00 +784.5%4.5%0.4 $5.65 1/15/202120,000 shares $99,000.00 +34.2%0.5%0 $4.95 12/31/202014,900 shares $64,368.00 -39.4%0.4%0.1 $4.32 12/15/202024,600 shares $122,505.54 -13.7%0.8%0.2 $4.98 11/30/202028,500 shares $150,195.00 -43.7%0.9%0.2 $5.27 11/15/202050,600 shares $271,216.00 -1.9%1.7%0.2 $5.36 10/30/202051,600 shares $323,532.00 -32.6%1.7%0.2 $6.27 10/15/202076,500 shares $569,160.00 -21.8%2.5%0.1 $7.44 9/30/202097,800 shares $789,246.00 +36.0%3.2%0.1 $8.07 9/15/202071,900 shares $504,738.00 -31.5%2.5%0.1 $7.02 8/31/2020104,900 shares $978,717.00 +28.1%3.2%0.1 $9.33 8/14/202081,900 shares $573,300.00 +7.8%2.8%0 $7.00 7/31/202076,000 shares $520,600.00 +46.4%2.8%0 $6.85 7/15/202051,900 shares $244,449.00 -30.2%1.9%0 $4.71 6/30/202074,400 shares $360,096.00 +1,330.8%2.8%0.1 $4.84 6/15/20205,200 shares $30,160.00 -62.3%0.2%0 $5.80 5/29/202013,800 shares $42,366.00 -37.8%0.5%0.2 $3.07 5/15/202022,200 shares $60,828.00 +85.0%0.8%0.4 $2.74 EDSA Short Interest - Frequently Asked Questions What is Edesa Biotech's current short interest? Short interest is the volume of Edesa Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 54,500 shares of EDSA short. 0.90% of Edesa Biotech's shares are currently sold short. Learn More on Edesa Biotech's current short interest. What is a good short interest percentage for Edesa Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.90% of Edesa Biotech's floating shares are currently sold short. Is Edesa Biotech's short interest increasing or decreasing? Edesa Biotech saw a decline in short interest in April. As of April 15th, there was short interest totaling 54,500 shares, a decline of 25.4% from the previous total of 73,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edesa Biotech's float size? Edesa Biotech currently has issued a total of 7,023,000 shares. Some of Edesa Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edesa Biotech currently has a public float of 6,070,000 shares. How does Edesa Biotech's short interest compare to its competitors? 0.90% of Edesa Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Edesa Biotech: Adagene Inc. (0.13%), Cabaletta Bio, Inc. (13.17%), Vistagen Therapeutics, Inc. (1.98%), I-Mab (0.67%), Alto Neuroscience, Inc. (14.14%), Clearside Biomedical, Inc. (0.73%), Pyxis Oncology, Inc. (16.29%), Rani Therapeutics Holdings, Inc. (10.27%), Metagenomi, Inc. (12.67%), IO Biotech, Inc. (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Edesa Biotech stock? Short selling EDSA is an investing strategy that aims to generate trading profit from Edesa Biotech as its price is falling. EDSA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edesa Biotech? A short squeeze for Edesa Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EDSA, which in turn drives the price of the stock up even further. How often is Edesa Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDSA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Adagene Short Interest Data Cabaletta Bio Short Interest Data Vistagen Therapeutics Short Interest Data I-Mab Short Interest Data Alto Neuroscience Short Interest Data Clearside Biomedical Short Interest Data Pyxis Oncology Short Interest Data Rani Therapeutics Short Interest Data Metagenomi Short Interest Data IO Biotech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDSA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EDSA Stock Free EDSA Stock Alerts